Non-Hodgkin's lymphoma: Present status and future prospects
被引:1
作者:
Habermann, TM
论文数: 0引用数: 0
h-index: 0
机构:
Mayo Med Sch, Dept Internal Med, Div Hematol, Rochester, MN 55901 USAMayo Med Sch, Dept Internal Med, Div Hematol, Rochester, MN 55901 USA
Habermann, TM
[1
]
机构:
[1] Mayo Med Sch, Dept Internal Med, Div Hematol, Rochester, MN 55901 USA
来源:
HOSPITAL PRACTICE
|
1999年
/
34卷
/
13期
关键词:
D O I:
10.3810/hp.1999.12.178
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Both management and prognosis vary with the many different varieties of non-Hodgkin's lymphoma, In large-cell disease, age and other risk factors influence prognosis. Relapses may respond to chemotherapy plus autologous bone marrow transplantation. Therapy with antibodies to tumor cells has made its debut, but its role remains unclear.